Effect of Methylnaltrexone (Relistor) on Digestion and Tolerance to Tube Feeding in Patients Treated With Opiates

Phase 3 Withdrawn Drexel University Wyeth is now a wholly owned subsidiary of Pfizer · collab

RandomizedParallel-groupTriple-blindTreatment

Summary

It is hypothesized that using methylnaltrexone in addition to pain killer narcotics (opiates) in patients will result in increased tube feeding rates with more frequent nutrition at goal calorie rate.

Timeline

Start: 2010-10
Primary completion: 2012-05
Completion: 2012-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Methylnaltrexone	Other / unclassified	8 mg	Intravenous
Comparator	Methylnaltrexone	Other / unclassified	12 mg	Intravenous

Indications

No indication recorded.